ADMA Biologics, Inc. (ADMA)
17.31
-0.19
(-1.09%)
USD |
NASDAQ |
Jan 16, 16:00
17.22
-0.09
(-0.52%)
Pre-Market: 08:50
ADMA Biologics Market Cap: 4.120B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcutis Biotherapeutics, Inc. | 3.166B |
| Vanda Pharmaceuticals, Inc. | 441.45M |
| Aldeyra Therapeutics, Inc. | 278.55M |
| Marker Therapeutics, Inc. | 30.18M |
| CorMedix, Inc. | 534.19M |
Market Cap Related Metrics
| PE Ratio | 20.33 |
| PS Ratio | 8.715 |
| PEG Ratio | 0.0977 |
| Price to Book Value | 9.554 |
| Price to Free Cash Flow | 104.85 |
| Price | 17.31 |
| Earnings Yield | 4.92% |
| PEGY Ratio | 0.0977 |
| Operating PE Ratio | 25.49 |
| Normalized PE Ratio | 20.02 |